Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
HSTM Stock Forecast 2025-2026
$27.82
Current Price
$855.78M
Market Cap
Buy 2
Hold 3
Sell 0
Wall St Analyst Ratings
Distance to HSTM Price Targets
+43.8%
To High Target of $40.00
+24.0%
To Median Target of $34.50
+4.2%
To Low Target of $29.00
HSTM Price Momentum
-2.4%
1 Week Change
-14.6%
1 Month Change
+3.1%
1 Year Change
-12.5%
Year-to-Date Change
-18.8%
From 52W High of $34.24
+7.7%
From 52W Low of $25.84
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching HealthStream (HSTM) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on HSTM and similar high-potential opportunities.
Latest HSTM Stock Price Targets & Analyst Predictions
Based on our analysis of 5 Wall Street analysts, HSTM has a neutral consensus with a median price target of $34.50 (ranging from $29.00 to $40.00). The overall analyst rating is Buy (7.6/10). Currently trading at $27.82, the median forecast implies a 24.0% upside. This outlook is supported by 2 Buy, 3 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Richard Close at Canaccord Genuity, suggesting a 4.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
HSTM Analyst Ratings
2
Buy
3
Hold
0
Sell
HSTM Price Target Range
Low
$29.00
Average
$34.50
High
$40.00
Current: $27.82
Latest HSTM Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for HSTM.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 15, 2025 | Canaccord Genuity | Richard Close | Hold | Maintains | $29.00 |
| Feb 26, 2025 | Canaccord Genuity | Richard Close | Hold | Maintains | $30.00 |
| Feb 6, 2025 | JMP Securities | Constantine Davides | Market Perform | Reiterates | $0.00 |
| Oct 23, 2024 | Canaccord Genuity | Richard Close | Hold | Maintains | $29.00 |
| Oct 23, 2024 | Barclays | Overweight | Maintains | $34.00 | |
| Jul 24, 2024 | Canaccord Genuity | Richard Close | Hold | Maintains | $28.00 |
| Dec 6, 2023 | JMP Securities | Constantine Davides | Market Perform | Initiates | $0.00 |
| Feb 22, 2023 | Canaccord Genuity | Richard Close | Hold | Maintains | $26.00 |
| Apr 28, 2021 | Canaccord Genuity | Richard Close | Hold | Maintains | $24.00 |
| Oct 28, 2020 | Canaccord Genuity | Hold | Maintains | $20.00 | |
| Dec 20, 2019 | Raymond James | Market Perform | Initiates | $0.00 | |
| Jul 11, 2018 | Barrington Research | Market Perform | Downgrade | $0.00 | |
| Jun 14, 2018 | Baird | Neutral | Downgrade | $0.00 | |
| Oct 25, 2017 | Baird | Matthew Gillmor | Outperform | Maintains | $28.00 |
| Oct 25, 2017 | Needham | Hold | Downgrade | $0.00 | |
| Jul 26, 2017 | First Analysis | Equal-Weight | Upgrade | $0.00 | |
| Jan 23, 2017 | First Analysis | Frank Sparacino | Underweight | Downgrade | $18.00 |
| Dec 2, 2016 | Baird | Outperform | Upgrade | $0.00 | |
| Nov 4, 2016 | Canaccord Genuity | Hold | Downgrade | $0.00 | |
| Nov 4, 2016 | Craig-Hallum | Hold | Downgrade | $0.00 |
HealthStream Inc. (HSTM) Competitors
The following stocks are similar to HealthStream based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
HSTM
HealthStream
mkt cap
841.58M
HealthStream Inc. (HSTM) Financial Data
HealthStream Inc. has a market capitalization of $855.78M with a P/E ratio of 44.5x. The company generates $292.37M in trailing twelve-month revenue with a 6.5% profit margin.
Revenue growth is +1.0% quarter-over-quarter, while maintaining an operating margin of +6.0% and return on equity of +5.4%.
Valuation Metrics
Market Cap
$855.78M
Enterprise Value
$765.35M
P/E Ratio
44.5x
PEG Ratio
43.8x
Price/Sales
2.9x
Growth & Margins
Revenue Growth (YoY)
+1.0%
Gross Margin
+65.3%
Operating Margin
+6.0%
Net Margin
+6.5%
EPS Growth
-17.1%
Financial Health
Cash/Price Ratio
+13.3%
Current Ratio
1.3x
Debt/Equity
4.6x
ROE
+5.4%
ROA
+2.4%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
HealthStream Inc. (HSTM) Business Model
About HealthStream Inc.
What They Do
Provides workforce solutions for the healthcare industry.
Business Model
HealthStream generates revenue by offering cloud-based solutions that enhance workforce performance for healthcare providers. Its services include training platforms, credentialing, and management tools designed to meet regulatory standards, thereby improving operational efficiency and compliance.
Additional Information
The company focuses on improving patient outcomes by ensuring that healthcare staff are well-trained and competent. HealthStream serves a niche market within the healthcare industry, making it a valuable player in a complex and evolving landscape.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
1,083
CEO
Mr. Robert A. Frist Jr.
Country
United States
IPO Year
2000
Website
www.healthstream.comHealthStream Inc. (HSTM) Latest News & Analysis
Latest News
HealthStream Announces Share Repurchase Program
14 days ago
Quick Summary
HealthStream (Nasdaq: HSTM) has authorized a $25 million share repurchase program for its common stock, allowing for purchases in the open market and under a Rule 10b5-1 plan.
Why It Matters
HealthStream's $25 million share repurchase program signals confidence in its financial health, potentially boosting stock value and indicating management's commitment to returning capital to shareholders.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
HealthStream, Inc. (NASDAQ:HSTM) will hold its Q1 2025 earnings call on May 6, 2025, at 9:00 AM ET, featuring key executives and analysts from various firms.
Why It Matters
HealthStream's Q1 2025 earnings call signals upcoming financial performance insights, impacting stock valuation and investor sentiment based on results and management commentary.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
HealthStream, Inc. reported Q1 2025 revenues of $73.5 million, up 1% year-over-year. Operating income decreased 23.1% to $4.4 million, with net income at $4.3 million.
Why It Matters
HealthStream's Q1 2025 revenue growth is marginal, but declining operating income raises concerns about profitability. Investors may reassess growth prospects and operational efficiency.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
HealthStream (HSTM) reported Q3 earnings of $0.14 per share, below the Zacks estimate of $0.16 and down from $0.17 per share a year earlier.
Why It Matters
HealthStream's earnings miss indicates potential operational challenges and may lead to negative sentiment, affecting stock performance and investor confidence.
Source: Zacks Investment Research
Market Sentiment:
Negative
Here's Why HealthStream (HSTM) is Poised for a Turnaround After Losing -13.2% in 4 Weeks
15 days ago
Quick Summary
HealthStream (HSTM) is now technically oversold, suggesting reduced selling pressure. Analysts are also raising earnings estimates, indicating a potential trend reversal ahead.
Why It Matters
HealthStream (HSTM) being oversold suggests a rebound may occur, while revised earnings estimates from analysts signal potential growth, presenting a buying opportunity for investors.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
Top-ranked stocks Fox (FOXA), Newmont (NEM), Affirm (AFRM), HealthStream (HSTM), and Iridium Communications (IRDM) are expected to exceed earnings forecasts in their upcoming releases.
Why It Matters
Positive earnings expectations for Fox, Newmont, Affirm, HealthStream, and Iridium could boost investor confidence and drive stock prices higher ahead of their releases.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About HSTM Stock
What is HealthStream Inc.'s (HSTM) stock forecast for 2025?
Based on our analysis of 5 Wall Street analysts, HealthStream Inc. (HSTM) has a median price target of $34.50. The highest price target is $40.00 and the lowest is $29.00.
Is HSTM stock a good investment in 2025?
According to current analyst ratings, HSTM has 2 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $27.82. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for HSTM stock?
Wall Street analysts predict HSTM stock could reach $34.50 in the next 12 months. This represents a 24.0% increase from the current price of $27.82. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is HealthStream Inc.'s business model?
HealthStream generates revenue by offering cloud-based solutions that enhance workforce performance for healthcare providers. Its services include training platforms, credentialing, and management tools designed to meet regulatory standards, thereby improving operational efficiency and compliance.
What is the highest forecasted price for HSTM HealthStream Inc.?
The highest price target for HSTM is $40.00 from at , which represents a 43.8% increase from the current price of $27.82.
What is the lowest forecasted price for HSTM HealthStream Inc.?
The lowest price target for HSTM is $29.00 from Richard Close at Canaccord Genuity, which represents a 4.2% increase from the current price of $27.82.
What is the overall HSTM consensus from analysts for HealthStream Inc.?
The overall analyst consensus for HSTM is neutral. Out of 5 Wall Street analysts, 2 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $34.50.
How accurate are HSTM stock price projections?
Stock price projections, including those for HealthStream Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 23, 2025 3:20 AM UTC